Clarus (NASDAQ:CLAR) Therapeutics (CRXT) reported Q1 EPS of ($0.61), $0.21 worse than the analyst estimate of ($0.40). Revenue for the quarter came in at $4 million versus the consensus...
- Day's Range
- 0.00 - 0.01
- 52 wk Range
- 0.01 - 3.94
- Prev. Close
- Average Vol.(3m)
- 1-Year Change
- Market Cap
- P/E Ratio
- United States
- Shares Outstanding
- Dividend (Yield)
- N/A (N/A%)
- Next Earnings Date
Investing.com – U.S. equities were higher at the close on Monday, as gains in the Technology, Consumer Services and Healthcare sectors propelled shares higher. At the close in NYSE, the Dow...
Investing.com – U.S. equities were mixed at the close on Wednesday, as gains in the Healthcare, Financials and Utilities sectors propelled shares higher while losses in the Consumer...
Investing.com – U.S. equities were lower at the close on Thursday, as losses in the Financials, Technology and Consumer Services sectors propelled shares lower. At the close in NYSE, the...
Investing.com – U.S. equities were mixed at the close on Friday, as gains in the Oil & Gas, Utilities and Financials sectors propelled shares higher while losses in the Technology, Consumer...
Investing.com – U.S. equities were lower at the close on Monday, as losses in the Consumer Services, Financials and Technology sectors propelled shares lower. At the close in NYSE, the Dow...
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.